82 related articles for article (PubMed ID: 15485655)
1. SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.
Huang L; Gotoh N; Zhang S; Shibuya M; Yamamoto T; Tsuchida N
Biochem Biophys Res Commun; 2004 Nov; 324(3):1011-7. PubMed ID: 15485655
[TBL] [Abstract][Full Text] [Related]
2. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
3. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
Wu Y; Chen Z; Ullrich A
Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
[TBL] [Abstract][Full Text] [Related]
4. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
5. FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
Li X; Brunton VG; Burgar HR; Wheldon LM; Heath JK
J Cell Sci; 2004 Dec; 117(Pt 25):6007-17. PubMed ID: 15564375
[TBL] [Abstract][Full Text] [Related]
6. Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation.
Chikamori M; Fujimoto J; Tokai-Nishizumi N; Yamamoto T
Oncogene; 2007 May; 26(20):2950-4. PubMed ID: 17086210
[TBL] [Abstract][Full Text] [Related]
7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton.
Harrison RE; Sikorski BA; Jongstra J
J Cell Sci; 2004 Apr; 117(Pt 10):2151-7. PubMed ID: 15090600
[TBL] [Abstract][Full Text] [Related]
9. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
10. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins.
Gotoh N
Cancer Sci; 2008 Jul; 99(7):1319-25. PubMed ID: 18452557
[TBL] [Abstract][Full Text] [Related]
11. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.
Mandl M; Slack DN; Keyse SM
Mol Cell Biol; 2005 Mar; 25(5):1830-45. PubMed ID: 15713638
[TBL] [Abstract][Full Text] [Related]
12. Grb2 negatively regulates epidermal growth factor-induced phospholipase C-gamma1 activity through the direct interaction with tyrosine-phosphorylated phospholipase C-gamma1.
Choi JH; Hong WP; Yun S; Kim HS; Lee JR; Park JB; Bae YS; Ryu SH; Suh PG
Cell Signal; 2005 Oct; 17(10):1289-99. PubMed ID: 16038803
[TBL] [Abstract][Full Text] [Related]
13. Albumin activates ERK via EGF receptor in human renal epithelial cells.
Reich H; Tritchler D; Herzenberg AM; Kassiri Z; Zhou X; Gao W; Scholey JW
J Am Soc Nephrol; 2005 May; 16(5):1266-78. PubMed ID: 15829704
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
[TBL] [Abstract][Full Text] [Related]
15. Genetically encoded bioluminescent indicator for ERK2 dimer in living cells.
Kaihara A; Umezawa Y
Chem Asian J; 2008 Jan; 3(1):38-45. PubMed ID: 18058892
[TBL] [Abstract][Full Text] [Related]
16. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
[TBL] [Abstract][Full Text] [Related]
17. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
18. Nurr1 is phosphorylated by ERK2 in vitro and its phosphorylation upregulates tyrosine hydroxylase expression in SH-SY5Y cells.
Zhang T; Jia N; Fei E; Wang P; Liao Z; Ding L; Yan M; Nukina N; Zhou J; Wang G
Neurosci Lett; 2007 Aug; 423(2):118-22. PubMed ID: 17681692
[TBL] [Abstract][Full Text] [Related]
19. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
20. Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin.
Yeh PY; Chuang SE; Yeh KH; Song YC; Cheng AL
Biochem Biophys Res Commun; 2001 Jun; 284(4):880-6. PubMed ID: 11409876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
